
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1083 | 944 | 1124 | 1200 | 1358 | 1693 |
Fund Return | 8.27% | -5.56% | 12.41% | 6.27% | 6.31% | 5.4% |
Place in category | 105 | 111 | 151 | 29 | 109 | 95 |
% in Category | 52 | 69 | 82 | 13 | 65 | 79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
James Alpha Global Real Estate InvI | 179.12M | 0.91 | -6.39 | 4.71 | ||
James Alpha Global Real Estate InvA | 33.5M | 0.45 | -6.75 | 4.27 | ||
Saratoga Large Capitalization Growi | 26.53M | 42.76 | 13.03 | 15.63 | ||
Saratoga Health Biotechnology Inst | 5.3M | 8.69 | 6.69 | 5.82 | ||
Saratoga Large Capitalization Growa | 2.38M | 42.27 | 12.57 | 15.17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 32.98B | 4.15 | 4.94 | 7.02 | ||
T. Rowe Price Health Sciences | 6.68B | 4.25 | 3.25 | 8.01 | ||
Fidelity Select Health Care | 6.42B | 2.50 | 3.68 | 7.60 | ||
Vanguard Health Care Inv | 5.95B | 4.15 | 4.89 | 6.97 | ||
T. Rowe Price Health Sciences I | 4.64B | 4.29 | 3.39 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amgen | US0311621009 | 5.40 | 287.80 | +2.69% | |
United Therapeutics | US91307C1027 | 4.90 | 291.70 | +4.29% | |
Tenet Healthcare | US88033G4073 | 4.85 | 130.35 | +9.07% | |
Intuitive Surgical | US46120E6023 | 4.77 | 516.77 | +12.92% | |
Regeneron Pharma | US75886F1075 | 4.75 | 574.33 | +3.15% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review